[1] 张浩然.18F-FDG PET/CT寻找肿瘤原发灶在临床中应用价值的分析[J].中国实验诊断学, 2013, 17(2):326-327.DOI:10.3969/j.issn.1007-4287.2013.02.042.
Zhang HR.Looking for tumor primary tumors in the clinical application value of analysis of 18F-FDG PET/CT[J].Chin J Lab Diagn, 2013, 17(2):326-327.  doi: 10.3969/j.issn.1007-4287.2013.02.042
[2] 宋建华, 赵晋华, 邢岩, 等.18F-FDG PET/CT对原发不明颈部淋巴结转移癌患者原发灶检出的价值[J].中华核医学与分子影像杂志, 2013, 33(6):417-420.DOI:10.3760/cma.j.issn.2095-2848.2013.06.004.
Song JH, Zhao JH, Xing Y, et al.18F-FDG PET/CT for the detection of primary malignancy in patients with cervical lymph node metastatses from unknown origin[J].Chin J Nucl Med Mol Imaging, 2013, 33(6):417-420.  doi: 10.3760/cma.j.issn.2095-2848.2013.06.004
[3] 张倩, 李亚明, 李雪娜.18F-FDG PET/CT在原发灶不明的淋巴结转移癌中的应用价值[J].中国医学影像技术, 2011, 27(9):1838-1841.DOI:10.3969/j.issn.1008-1062.2011.06.009.
Zhang Q, Li YM, Li XN.Value of 18F-FDG PET/CT imaging in metastatic lymph node carcinoma of unknown primary site[J].Chin J Med Imaging Technol, 2011, 27(9):1838-1841.  doi: 10.3969/j.issn.1008-1062.2011.06.009
[4] Kole AC, Nieweg OE, Hoekstra HJ, et al.Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors[J].J Nucl Med, 1998, 39(5):810-815.
[5] Yaylali O, Kirac FS, Yuksel D.The role of 18F-FDG PET-CT in the detection of unknown primary malignancy:a retrospective study[J].Turk J Med Sci, 2016, 46(2):474-482.DOI:10.3906/sag-1502-99.
[6] 刘红红, 兰晓莉, Anand G, 等.18F-FDG PET/CT对原发灶不明颈部淋巴结转移癌的诊断及预后价值[J].中华核医学与分子影像杂志, 2016, 36(1):48-53.DOI:10.3760/cma.j.issn.2095-2848.2016.01.012.
Liu HH, Lan XL, Anand G, et al.Diagnostic and prognostic values of 18F-FDG PET/CT in cervical nodal metastatic carcinoma of un-known primary site[J].Chin J Nucl Med Mol Imaging, 2016, 36(1):48-53.  doi: 10.3760/cma.j.issn.2095-2848.2016.01.012
[7] 倪晓光, 程荣荣, 赖少清, 等.窄带成像内镜在原发灶不明的颈部转移性鳞癌诊断中的作用[J].中华肿瘤杂志, 2013, 35(9):698-702.DOI:10.3760/cma.j.issn.0253-3766.2013.09.012.
Ni XG, Cheng RR, Lai SQ, et al.Value of narrow band imaging endoscopy in the detection of unknown primary site with cervical lymph node metastasis of squamous cell carcinoma[J].Chin J Oncol, 2013, 35(9):698-702.  doi: 10.3760/cma.j.issn.0253-3766.2013.09.012
[8] 贾晓娟, 韩军, 许泽清, 等.18F-FDG SPECT/CT检查在原发癌灶定位诊断中的意义[J].中外医疗, 2013, 32(22):24, 27.DOI:10.3969/j.issn.1674-0742.2013.22.012.
Jia XJ, Han J, Xu ZQ, et al.The value of 18F-FDG SPECT/CT examination in detecting primary tumor for patients with carcinoma of unknown primary[J].Chin For Med Treat, 2013, 32(22):24, 27.  doi: 10.3969/j.issn.1674-0742.2013.22.012
[9] 邓家琦, 付文广, 雷正明, 等.18F-FDG PET/CT对腹部增强CT术前评估肝癌远处转移的价值[J].重庆医学, 2016, 45(13):1756-1758.DOI:10.3969/j.issn.1671-8348.2016.13.009.
Deng JQ, Fu WG, Lei ZM, et al.Value of 18F-FDG PET/CT in abdominal contrast-enhanced CT for preoperatively evaluating distant metastasis of liver cancer[J].Chongqing Med, 2016, 45(13):1756-1758.  doi: 10.3969/j.issn.1671-8348.2016.13.009
[10] 魏昊, 兰晓莉, 廖姗珊, 等.18F-FDG PET/CT代谢显像在结直肠癌患者孤立性肺结节中的应用[J].放射学实践, 2015, 30(8):869-872.DOI:10.13609/j.cnki.1000-0313.2015.08.016.
Wei H, Lan XL, Liao SS, et al.The role of 18F-FDG PET/CT imaging in the evaluation of solitary pulmonary nodules in patients with colorectal cancer[J].Radiol Practice, 2015, 30(8):869-872.  doi: 10.13609/j.cnki.1000-0313.2015.08.016
[11]

鲍俊初. 18F-FDG PET/CT显像在胃癌术后复发和转移中的诊断价值[D]. 广州: 南方医科大学, 2011.

Bao JC.Diagnostic value of postoperative gastric cancer recurrence and metastasis of 18F-FDG PET/CT[D].Guangzhou:Southern Medical University, 2011.

[12] 陈万青, 张思维, 曾红梅, 等.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤, 2014, 23(1):1-10.DOI:10.11735/j.issn.1004-0242.2014.01.A001.
Chen WQ, Zhang SW, Zeng HM, et al.Report of cancer incidence and mortality in China, 2010[J].China Cancer, 2014, 23(1):1-10.  doi: 10.11735/j.issn.1004-0242.2014.01.A001
[13] 李生栩, 唐明灯, 林端瑜, 等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志, 2016, 40(6):408-413.DOI:10.3760/cma.j.issn.1673-4114.2016.06.002.
Li SX, Tang MD, Lin DY, et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].Int J Radiat Med Nucl Med, 2016, 40(6):408-413.  doi: 10.3760/cma.j.issn.1673-4114.2016.06.002